Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan (PERFORM-J): Protocol for a Prospective Cohort Study.

about

Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan (PERFORM-J): Protocol for a Prospective Cohort Study.

Item

http://www.wikidata.org/entity/Q55686132

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prospective Epidemiological Re ...... or a Prospective Cohort Study.

@en

Prospective Epidemiological Re ...... r Depressive Disorder in Japan

@nl

type

Item

label

Prospective Epidemiological Re ...... or a Prospective Cohort Study.

@en

Prospective Epidemiological Re ...... r Depressive Disorder in Japan

@nl

prefLabel

Prospective Epidemiological Re ...... or a Prospective Cohort Study.

@en

Prospective Epidemiological Re ...... r Depressive Disorder in Japan

@nl

P1476

Prospective Epidemiological Re ...... for a Prospective Cohort Study

@en

P2093

Koichiro Watanabe

http://www.w3.org/2001/XMLSchema#string

Shigeru Sakamoto

http://www.w3.org/2001/XMLSchema#string

Shinichi Noto

http://www.w3.org/2001/XMLSchema#string

Shuichi Okamoto

http://www.w3.org/2001/XMLSchema#string

Tomiki Sumiyoshi

http://www.w3.org/2001/XMLSchema#string

Yoshiya Moriguchi

http://www.w3.org/2001/XMLSchema#string

P2860

The PHQ-9: validity of a brief depression severity measure

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

A new depression scale designed to be sensitive to change

Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys.

The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome.

A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults.

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment.

Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative.

A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

P304

e161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2196/RESPROT.9682

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29941418

http://www.w3.org/2001/XMLSchema#string

P932

6037943

http://www.w3.org/2001/XMLSchema#string